Lyon, France, November 14, 2014 - ERYTECH (Euronext Paris: FR0011471135 – ERYP), the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology indications with unmet medical need, will be presenting at Jefferies Global Healthcare …
The post ERYTECH to present at Jefferies Global Healthcare Conference appeared first on Erytech Pharma.
